125 related articles for article (PubMed ID: 33141923)
21. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans.
Chu X; Shih SJ; Shaw R; Hentze H; Chan GH; Owens K; Wang S; Cai X; Newton D; Castro-Perez J; Salituro G; Palamanda J; Fernandis A; Ng CK; Liaw A; Savage MJ; Evers R
Drug Metab Dispos; 2015 Jun; 43(6):851-63. PubMed ID: 25813937
[TBL] [Abstract][Full Text] [Related]
23. Elucidating the effect of final-day dosing of rifampin in induction studies on hepatic drug disposition and metabolism.
Lam JL; Shugarts SB; Okochi H; Benet LZ
J Pharmacol Exp Ther; 2006 Nov; 319(2):864-70. PubMed ID: 16905688
[TBL] [Abstract][Full Text] [Related]
24. Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation.
Shen H; Yang Z; Mintier G; Han YH; Chen C; Balimane P; Jemal M; Zhao W; Zhang R; Kallipatti S; Selvam S; Sukrutharaj S; Krishnamurthy P; Marathe P; Rodrigues AD
J Pharmacol Exp Ther; 2013 Mar; 344(3):673-85. PubMed ID: 23297161
[TBL] [Abstract][Full Text] [Related]
25. Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease.
Eley T; Han YH; Huang SP; He B; Li W; Bedford W; Stonier M; Gardiner D; Sims K; Rodrigues AD; Bertz RJ
Clin Pharmacol Ther; 2015 Feb; 97(2):159-66. PubMed ID: 25670521
[TBL] [Abstract][Full Text] [Related]
26. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
Badolo L; Bundgaard C; Garmer M; Jensen B
Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
[TBL] [Abstract][Full Text] [Related]
27. Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition.
Gu X; Wang L; Gan J; Fancher RM; Tian Y; Hong Y; Lai Y; Sinz M; Shen H
Drug Metab Dispos; 2020 Aug; 48(8):724-734. PubMed ID: 32482623
[TBL] [Abstract][Full Text] [Related]
28. Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides.
Thakare R; Gao H; Kosa RE; Bi YA; Varma MVS; Cerny MA; Sharma R; Kuhn M; Huang B; Liu Y; Yu A; Walker GS; Niosi M; Tremaine L; Alnouti Y; Rodrigues AD
Drug Metab Dispos; 2017 Jul; 45(7):721-733. PubMed ID: 28396527
[TBL] [Abstract][Full Text] [Related]
29. Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin.
Varma MV; Lin J; Bi YA; Rotter CJ; Fahmi OA; Lam JL; El-Kattan AF; Goosen TC; Lai Y
Drug Metab Dispos; 2013 May; 41(5):966-74. PubMed ID: 23393219
[TBL] [Abstract][Full Text] [Related]
30. effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.
Lau YY; Huang Y; Frassetto L; Benet LZ
Clin Pharmacol Ther; 2007 Feb; 81(2):194-204. PubMed ID: 17192770
[TBL] [Abstract][Full Text] [Related]
31. Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans.
Mikkaichi T; Nakai D; Yoshigae Y; Imaoka T; Okudaira N; Izumi T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):334-40. PubMed ID: 26403085
[TBL] [Abstract][Full Text] [Related]
32. Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions.
Nishizawa K; Nakanishi T; Tamai I
Drug Metab Dispos; 2017 Feb; 45(2):224-227. PubMed ID: 27934638
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.
Yee KL; Khalilieh SG; Sanchez RI; Liu R; Anderson MS; Manthos H; Judge T; Brejda J; Butterton JR
Clin Drug Investig; 2017 Jul; 37(7):659-667. PubMed ID: 28353169
[TBL] [Abstract][Full Text] [Related]
34. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
Treiber A; Schneiter R; Häusler S; Stieger B
Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
[TBL] [Abstract][Full Text] [Related]
35. Influence of rifampicin on the pharmacokinetics of salvianolic acid B may involve inhibition of organic anion transporting polypeptide (Oatp) mediated influx.
Zhao D; Gao ZD; Han DE; Li N; Zhang YJ; Lu Y; Li TT; Chen XJ
Phytother Res; 2012 Jan; 26(1):118-21. PubMed ID: 21567510
[TBL] [Abstract][Full Text] [Related]
36. PET imaging of Oatp-mediated hepatobiliary transport of [(11)C] rosuvastatin in the rat.
He J; Yu Y; Prasad B; Link J; Miyaoka RS; Chen X; Unadkat JD
Mol Pharm; 2014 Aug; 11(8):2745-54. PubMed ID: 24957348
[TBL] [Abstract][Full Text] [Related]
37. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
[TBL] [Abstract][Full Text] [Related]
38. Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings.
Ziesenitz VC; König SK; Mahlke N; Jantos R; Skopp G; Weiss J; Haefeli WE; Mikus G
Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):43-8. PubMed ID: 23480028
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Long-Lasting Oatp Inhibition by Typical Inhibitor Cyclosporine A and In Vitro-In Vivo Discrepancy in Its Drug Interaction Potential in Rats.
Taguchi T; Masuo Y; Kogi T; Nakamichi N; Kato Y
J Pharm Sci; 2016 Jul; 105(7):2231-9. PubMed ID: 27290622
[TBL] [Abstract][Full Text] [Related]
40. Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans.
Beysen C; Ruddy M; Stoch A; Mixson L; Rosko K; Riiff T; Turner SM; Hellerstein MK; Murphy EJ
Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E126-E132. PubMed ID: 29558206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
